dostęp otwarty
Schizofrenia u dzieci i młodzieży - biologiczne uwarunkowania diagnozy i leczenia
dostęp otwarty
Streszczenie
Psychiatria 2010; 7, 4: 161-167
Streszczenie
Psychiatria 2010; 7, 4: 161-167
Słowa kluczowe
schizofrenia o wczesnym początku; schizofrenia o początku w wieku dziecięcym; badania neuroobrazowe; farmakoterapia
Tytuł
Schizofrenia u dzieci i młodzieży - biologiczne uwarunkowania diagnozy i leczenia
Czasopismo
Numer
Typ artykułu
Artykuł przeglądowy
Strony
161-167
Opublikowany online
2010-09-13
Wyświetlenia strony
2386
Wyświetlenia/pobrania artykułu
5492
Rekord bibliograficzny
Psychiatria 2010;7(4):161-167.
Słowa kluczowe
schizofrenia o wczesnym początku
schizofrenia o początku w wieku dziecięcym
badania neuroobrazowe
farmakoterapia
Autorzy
Aleksandra Rajewska-Rager
Andrzej Rajewski
- Masi G, Pfanner C, Mucci M, et al. Children with schizophrenia: clinical picture and pharmacological treatment. CNS Drugs. 2006; 20(10): 841–866.
- Shioiri T, Shinada K, Kuwabara H, et al. Early prodromal symptoms and diagnoses before first psychotic episode in 219 inpatients with schizophrenia. Psychiatry Clin Neurosci. 2007; 61(4): 348–354.
- Remschmidt H. Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J Neural Transm (Vienna). 2002; 109(1): 101–117.
- Selten JP, Veen ND, Hoek HW, et al. Early course of schizophrenia in a representative Dutch incidence cohort. Schizophr Res. 2007; 97(1-3): 79–87.
- Nicolson R, Lenane M, Singaracharlu S, et al. Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry. 2000; 157(5): 794–800.
- Rabinowitz J, Levine SZ, Häfner H. A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr Res. 2006; 88(1-3): 96–101.
- Fraguas D, de Castro MJ, Medina O, et al. Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev. 2008; 39(2): 137–145.
- Nicolson R, Brookner FB, Lenane M, et al. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry. 2003; 160(3): 490–495.
- Di Forti M, Morgan C, Dazzan P, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry. 2009; 195(6): 488–491.
- Chance SA, Casanova MF, Switala AE, et al. A review of MRI findings in schizophrenia. Schizophr Res. 2001; 49(1-2): 1–52.
- Douaud G, Mackay C, Andersson J, et al. Schizophrenia delays and alters maturation of the brain in adolescence. Brain. 2009; 132(Pt 9): 2437–2448.
- Sowell ER, Levitt J, Thompson PM, et al. Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am J Psychiatry. 2000; 157(9): 1475–1484.
- Janssen J, Reig S, Parellada M, et al. Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry. 2008; 47(11): 1311–1320.
- Pagsberg AK, Baaré WFC, Raabjerg Christensen AM, et al. Structural brain abnormalities in early onset first-episode psychosis. J Neural Transm (Vienna). 2007; 114(4): 489–498.
- Nugent TF, Herman DH, Ordonez A, et al. Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophr Res. 2007; 90(1-3): 62–70.
- Arango C, Moreno C, Martínez S, et al. Longitudinal brain changes in early-onset psychosis. Schizophr Bull. 2008; 34(2): 341–353.
- Brans RGH, van Haren NEM, van Baal GC, et al. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch Gen Psychiatry. 2008; 65(11): 1259–1268.
- Ashtari M, Cervellione KL, Hasan KM, et al. White matter development during late adolescence in healthy males: a cross-sectional diffusion tensor imaging study. Neuroimage. 2007; 35(2): 501–510.
- White T, Cullen K, Rohrer LM, et al. Limbic structures and networks in children and adolescents with schizophrenia. Schizophr Bull. 2008; 34(1): 18–29.
- Douaud G, Smith S, Jenkinson M, et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain. 2007; 130(Pt 9): 2375–2386.
- Kyriakopoulos M, Vyas NS, Barker GJ, et al. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry. 2008; 63(5): 519–523.
- Kumra S, Ashtari M, McMeniman M, et al. Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biol Psychiatry. 2004; 55(12): 1138–1145.
- White T, Kendi AT, Lehéricy S, et al. Disruption of hippocampal connectivity in children and adolescents with schizophrenia--a voxel-based diffusion tensor imaging study. Schizophr Res. 2007; 90(1-3): 302–307.
- O'Neill J, Levitt J, Caplan R, et al. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage. 2004; 21(4): 1781–1789.
- Stanley JA, Vemulapalli M, Nutche J, et al. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res. 2007; 93(1-3): 23–32.
- Kumra S, Sporn A, Hommer DW, et al. Smooth pursuit eye-tracking impairment in childhood-onset psychotic disorders. Am J Psychiatry. 2001; 158(8): 1291–1298.
- Sporn A, Greenstein D, Gogtay N, et al. Childhood-onset schizophrenia: smooth pursuit eye-tracking dysfunction in family members. Schizophr Res. 2005; 73(2-3): 243–252.
- Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 2000; 157(4): 549–559.
- Gochman PA, Greenstein D, Sporn A, et al. IQ stabilization in childhood-onset schizophrenia. Schizophr Res. 2005; 77(2-3): 271–277.
- Frangou S, Hadjulis M, Vourdas A. The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophr Bull. 2008; 34(1): 52–59.
- Varnäs K, Lawyer G, Jönsson EG, et al. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatr Genet. 2008; 18(4): 177–183.
- Mata I, Perez-Iglesias R, Roiz-Santiañez R, et al. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol Psychiatry. 2009; 65(6): 535–540.
- Potkin SG, Turner JA, Guffanti G, et al. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry. 2009; 14(4-5): 391–418.
- Kumra S, Frazier JA, Jacobsen LK, et al. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry. 1996; 53(12): 1090–1097.
- Sikich L, Hamer RM, Bashford RA, et al. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Neuropsychopharmacology. 2004; 29(1): 133–145.
- Kranzler H, Roofeh D, Gerbino-Rosen G, et al. Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2005; 44(1): 55–63.
- Haas M, Unis AS, Armenteros J, et al. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia. J Child Adolesc Psychopharmacol. 2009; 19(6): 611–621.
- Shaw P, Sporn A, Gogtay N, et al. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry. 2006; 63(7): 721–730.
- Kumra S, Kranzler H, Gerbino-Rosen G, et al. Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study. J Child Adolesc Psychopharmacol. 2008; 18(4): 307–316.
- Haas M, Eerdekens M, Kushner S, et al. Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: double-blind study. Br J Psychiatry. 2009; 194(2): 158–164.
- Sikich L, Frazier JA, McClellan J, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry. 2008; 165(11): 1420–1431.
- Findling RL, Robb A, Nyilas M, et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry. 2008; 165(11): 1432–1441.